Swiss All Share Index

Swiss All Share Index handeln
19.785,85 PKT -95,35 PKT -0,48 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
20.04.20 Nestlé Underperform RBC Capital Markets
17.04.20 Roche overweight JP Morgan Chase & Co.
17.04.20 DocMorris buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
17.04.20 UBS Outperform Credit Suisse Group
17.04.20 Holcim buy UBS AG
16.04.20 UBS Reduce Oddo BHF
16.04.20 UBS Reduce Oddo BHF
16.04.20 DocMorris overweight Barclays Capital
16.04.20 DocMorris buy Baader Bank
16.04.20 Roche overweight JP Morgan Chase & Co.
16.04.20 ams-OSRAM Underweight Barclays Capital
16.04.20 Holcim overweight JP Morgan Chase & Co.
16.04.20 ABB (Asea Brown Boveri) Hold HSBC
16.04.20 Nestlé Hold HSBC
15.04.20 Swiss Re buy UBS AG
15.04.20 Zurich Insurance buy UBS AG
15.04.20 Roche buy Jefferies & Company Inc.
15.04.20 Novartis buy Jefferies & Company Inc.
15.04.20 Nestlé Neutral Credit Suisse Group
14.04.20 Nestlé add Baader Bank
14.04.20 Zurich Insurance Hold Kepler Cheuvreux
14.04.20 UBS Underweight Barclays Capital
14.04.20 UBS Underweight Barclays Capital
09.04.20 Swiss Re Hold Jefferies & Company Inc.
09.04.20 Givaudan Underperform Credit Suisse Group
09.04.20 UBS Sector Perform RBC Capital Markets
09.04.20 UBS Sector Perform RBC Capital Markets
09.04.20 ABB (Asea Brown Boveri) Underweight JP Morgan Chase & Co.
09.04.20 UBS overweight Morgan Stanley
09.04.20 UBS Equal-Weight Morgan Stanley
09.04.20 Nestlé overweight Morgan Stanley
09.04.20 Swiss Re overweight JP Morgan Chase & Co.
09.04.20 UBS buy Kepler Cheuvreux
09.04.20 Roche overweight Barclays Capital
09.04.20 UBS Outperform Credit Suisse Group
09.04.20 Zurich Insurance Outperform Credit Suisse Group
09.04.20 Swiss Re Outperform Credit Suisse Group
09.04.20 Givaudan buy UBS AG
08.04.20 Givaudan Underperform Credit Suisse Group
08.04.20 Givaudan buy UBS AG